GE HealthCare Technologies PCS — Total revenues decreased by 14.6% to $704.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 6.5%, from $753.00M to $704.00M. Over 4 years (FY 2021 to FY 2025), PCS — Total revenues shows relatively stable performance with a 1.4% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates higher market adoption or pricing power for patient monitoring and clinical care equipment.
Represents the total gross income generated by the Patient Care Solutions segment from the sale of medical monitoring, a...
Standard revenue reporting for medical device segments across peer healthcare technology firms.
gehc_segment_pcs_total_revenues| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $728.75M | $728.75M | $728.75M | $716.00M | $713.00M | $701.00M | $786.00M | $781.00M | $770.00M | $764.00M | $827.00M | $747.00M | $772.00M | $779.00M | $827.00M | $753.00M | $778.00M | $731.00M | $824.00M | $704.00M |
| QoQ Change | — | +0.0% | +0.0% | -1.7% | -0.4% | -1.7% | +12.1% | -0.6% | -1.4% | -0.8% | +8.2% | -9.7% | +3.3% | +0.9% | +6.2% | -8.9% | +3.3% | -6.0% | +12.7% | -14.6% |
| YoY Change | — | — | — | — | -2.2% | -3.8% | +7.9% | +9.1% | +8.0% | +9.0% | +5.2% | -4.4% | +0.3% | +2.0% | +0.0% | +0.8% | +0.8% | -6.2% | -0.4% | -6.5% |